Michael Mangone
Vice President, Corporate Development
Professional Overview
Michael Mangone is an accomplished corporate development executive with over 15 years of experience in the biopharmaceutical industry. He currently serves as the Vice President of Corporate Development at Simcha Therapeutics, where he leads strategic initiatives to drive the company's growth and expansion. Mangone also holds concurrent roles as the Vice President of Business Development and Operations at Origin Biosciences and Phoenix Tissue Repair, Inc.
Experience Summary
Current Roles
As the Vice President of Corporate Development at Simcha Therapeutics, Mangone is responsible for spearheading the company's mergers and acquisitions strategy, identifying and evaluating potential partnerships, and overseeingintegration efforts. Under his leadership, Simcha has successfully completed two strategic acquisitions, expanding its pipeline and technological capabilities. Additionally, Mangone has secured several high-profile licensing agreements, positioning the company as a leader in its field.
At Origin Biosciences and Phoenix Tissue Repair, Inc., Mangone serves as the Vice President of Business Development and Operations. In this dual role, he is instrumental in driving the companies' growth initiatives, including new product introductions, market expansion, and operational optimization. Mangone's strategic vision and cross-functional collaboration have been instrumental in helping these organizations achieve significant milestones and revenue targets.
Career Progression
Prior to his current roles, Mangone was a Senior Consultant at ClearView Healthcare Partners, where he provided strategic advisory services to leading biopharmaceutical and medical device companies. His earlier career included positions as a Consultant at ClearView, a Postdoctoral Research Scientist at Columbia University Medical Center, and a Research Analyst Intern at SwitchBiotics, Inc. Mangone's diverse background in both industry and academia has equipped him with a unique blend of technical expertise and commercial acumen.
Academic Background
Mangone holds a Ph.D. in Molecular Biology from New York University, where his research focused on developing novel therapeutic approaches for rare genetic disorders. He also earned a Bachelor of Science degree in Biotechnology from Princeton University, graduating with honors.
Areas of Expertise
- Corporate development and strategic planning
- Mergers, acquisitions, and integration
- Business development and partnership management
- Operational excellence and organizational optimization
- Scientific and technical expertise in biotechnology and biopharmaceuticals
Professional Impact
Throughout his career, Mangone has demonstrated a track record of driving transformative change and delivering tangible results. His leadership in corporate development has enabled Simcha Therapeutics to expand its product portfolio and reach new patient populations. Similarly, his business development initiatives at Origin Biosciences and Phoenix Tissue Repair have contributed to significant revenue growth and market share gains.
Mangone is recognized as a thought leader in the industry, frequently speaking at industry conferences and contributing to peer-reviewed publications. His ability to bridge the gap between scientific innovation and commercial success has made him a valuable asset to the organizations he serves.
Conclusion
With his extensive experience, strategic vision, and exceptional leadership skills, Michael Mangone is poised to continue driving growth and innovation in the biopharmaceutical industry. As he advances in his career, he remains committed to leveraging his expertise to create meaningful impact for his organizations, stakeholders, and ultimately, the patients they serve.
